R
Rivka Ishai-Michaeli
Researcher at Hebrew University of Jerusalem
Publications - 29
Citations - 4932
Rivka Ishai-Michaeli is an academic researcher from Hebrew University of Jerusalem. The author has contributed to research in topics: Heparanase & Heparan sulfate. The author has an hindex of 24, co-authored 29 publications receiving 4804 citations.
Papers
More filters
Journal ArticleDOI
Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix
Israel Vlodavsky,Judah Folkman,Robert K. P. Sullivan,Rafael Fridman,Rivka Ishai-Michaeli,Joachim Sasse,Michael Klagsbrun +6 more
TL;DR: It is suggested that endothelium can store growth factors capable of autocrine growth promotion in two ways: by sequestering growth factor within the cell and by incorporating it into the underlying extracellular matrix.
Journal ArticleDOI
Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis.
Israel Vlodavsky,Yael Friedmann,Michael Elkin,Helena Aingorn,Ruth Atzmon,Rivka Ishai-Michaeli,Menachem Bitan,Orit Pappo,Tuvia Peretz,Israel Michal,Larissa Spector,Iris Pecker +11 more
TL;DR: This represents the first cloned mammalian heparanase, to the authors' knowledge, and provides direct evidence for its role in tumor metastasis, and enables the development of specific molecular probes for early detection and treatment of cancer metastasis and autoimmune disorders.
Journal Article
Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.
Israel Vlodavsky,Amiram Eldor,A. Haimovitz-Friedman,Yaacov Matzner,Rivka Ishai-Michaeli,O Lider,Yaakov Naparstek,Irun R. Cohen,Zvi Fuks +8 more
TL;DR: It is suggested that heparanase is utilized for this purpose by both normal leukocytic cells and metastatic tumor cells, and may elicit an indirect neovascular response in processes such as wound repair, inflammation and tumor development.
Journal ArticleDOI
Heparanase as mediator of angiogenesis: mode of action
Michael Elkin,Neta Ilan,Rivka Ishai-Michaeli,Yael Friedmann,Orit Papo,Iris Pecker,Israel Vlodavsky +6 more
TL;DR: The angiogenic effect of heparanase was demonstrated in vivo by showing a three‐ to fourfold increase in neovascularization induced by murine T‐lymphoma cells after stable transfection with the heparinase gene.
Journal ArticleDOI
Extracellular matrix-resident basic fibroblast growth factor: implication for the control of angiogenesis.
Israel Vlodavsky,Zvi Fuks,Rivka Ishai-Michaeli,Pnina Bashkin,Ehud Levi,Gil Korner,Rachel Bar-Shavit,Michael Klagsbrun +7 more
TL;DR: Results and studies on the properties of other ECM‐immobilized enzymes and growth factors suggest that the ECM provides a storage depot for biologically active molecules which are thereby stabilized and protected and may allow a more localized and presistent mode of action, as compared to the same molecules in a fluid phase.